ARCHIVES

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

This article is from The Cancer Letter archive.

Vol. 17 No. 28 | July 12, 1991

Download PDF Visit The Full Archive

Related Articles

Emory’s Winship Cancer Institute Wins NCI Cancer Center Designation

April 17, 2009

NCI-Approved Clinical Trials

January 27, 2006

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

June 28, 2002

NCAB Can’t Decide Fate of Women’s Health Trial, Forces It Back Into Lap of DCPC Scientific Advisors

October 2, 1987

Edward Benz Named President Of Dana-Farber Cancer Institute.

July 28, 2000

713 Nurses Pass Certification exam At ONS Congress

July 8, 1988